Capital Cs Group, LLC Novo Nordisk A S Transaction History
Capital Cs Group, LLC
- $146 Million
- Q3 2024
A detailed history of Capital Cs Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Capital Cs Group, LLC holds 75,100 shares of NVO stock, worth $7.97 Million. This represents 5.77% of its overall portfolio holdings.
Number of Shares
75,100Holding current value
$7.97 Million% of portfolio
5.77%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,955Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.14 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.52 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.52 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.41 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.3 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $240B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...